PMGC HOLDINGS INC. Unrealized Gain (Loss) on Derivatives
PMGC HOLDINGS INC. (ELAB) reported Unrealized Gain (Loss) on Derivatives of -$91.01 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-29.
Discontinued › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnDerivatives · last filed 2024-03-29
- PMGC HOLDINGS INC. unrealized gain (loss) on derivatives for the quarter ending 2023-12-31 was $84.73M, a 163.61% increase year-over-year.
- PMGC HOLDINGS INC. unrealized gain (loss) on derivatives for the quarter ending 2023-09-30 was -$9.10M.
- PMGC HOLDINGS INC. unrealized gain (loss) on derivatives for the quarter ending 2022-12-31 was $32.14M.
- PMGC HOLDINGS INC. unrealized gain (loss) on derivatives for the quarter ending 2022-09-30 was -$18.43M.
- PMGC HOLDINGS INC. unrealized gain (loss) on derivatives for fiscal 2023 was -$91.01K.
- PMGC HOLDINGS INC. unrealized gain (loss) on derivatives for fiscal 2022 was -$74.00K.
| Period end | Unrealized Gain (Loss) on Derivatives 3 month | Unrealized Gain (Loss) on Derivatives 6 month | Unrealized Gain (Loss) on Derivatives 9 month | Unrealized Gain (Loss) on Derivatives 12 month |
|---|---|---|---|---|
| 2023-12-31 | $84.73M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $75.63M derived: sum of 2 quarters · filed 2024-03-29 | -$91.01K 10-K · filed 2024-03-29 | |
| 2023-09-30 | -$9.10M 10-Q · filed 2023-12-11 | -$84.82M 10-Q · filed 2023-12-11 | ||
| 2022-12-31 | $32.14M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $13.71M derived: sum of 2 quarters · filed 2024-03-29 | -$74.00K 10-K · filed 2024-03-29 | |
| 2022-09-30 | -$18.43M 10-Q · filed 2023-12-11 | -$32.22M 10-Q · filed 2023-12-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |